Skip to main content Accessibility help
×
×
Home

A guide to new anticoagulant medications for ENT surgeons

  • M Bajalan (a1), T C Biggs (a1), S Jayaram (a2), J Mainwaring (a3) and R Salib (a1)...

Abstract

Objectives:

This study aimed to ascertain otolaryngologists’ current knowledge of new (e.g. apixaban, rivaroxaban) and old (e.g. warfarin) anticoagulant medications, and to provide an educational overview of new anticoagulants for use by surgeons.

Methods:

A questionnaire survey was distributed across the Wessex region, UK, to ascertain the levels of knowledge of and confidence in managing patients taking various anticoagulants. In total, 50 questionnaires were completed (41 by trainees and 9 by consultants). A literature review of new anticoagulant medications was then conducted.

Results:

In general, there was poor clinical and pharmacokinetic knowledge of newly licensed anticoagulant medications. Respondents were more confident in the use of older vs newer forms of anticoagulants. This was true across all grades of doctors, but particularly at the senior level. All respondents stated that they would like to see an educational resource on anticoagulants.

Conclusion:

Knowledge of newly licensed anticoagulation medications is poor. This study has produced an educational resource for the management of anticoagulant agents. A thorough knowledge of these drugs is essential for the acute management of bleeding patients and in peri-operative surgical planning.

Copyright

Corresponding author

Address for correspondence: Dr M Bajalan, 33 Fordbridge Road, Ashford, Middlesex TW15 2TB, UK E-mail: mobajalan@gmail.com

Footnotes

Hide All

Presented as an oral presentation at the South West ENT Academic Meeting, 6 June 2014, Bath, UK

Footnotes

References

Hide All
1National Institute for Health and Care Excellence. The management of atrial fibrillation. In: http://guidance.nice.org.uk/CG36 [1 June 2014]
2Sardella, G, Mancone, M, Biondi-Zoccai, G, Conti, G, Canali, E, Stio, R et al. Beneficial impact of prolonged dual antiplatelet therapy after drug-eluting stent implantation. J Interv Cardiol 2012;25:596603
3Smith, J, Siddiq, S, Dyer, C, Rainsbury, J, Kim, D. Epistaxis in patients taking oral anticoagulant and antiplatelet medication: prospective cohort study. J Laryngol Otol 2011;125:3842
4Vedovati, MC, Becattini, C, Agnelli, G. Combined oral anticoagulants and antiplatelets: benefits and risks. Intern Emerg Med 2010;5:281–90
5Hollowell, J, Ruigómez, A, Johansson, S, Wallander, MA, García-Rodríguez, LA. The incidence of bleeding complications associated with warfarin treatment in general practice in the United Kingdom. Br J Gen Pract 2003;53:312–14
6De Caterina, R, Husted, S, Wallentin, L, Andreotti, F, Arnesen, H, Bachmann, F et al. New oral anticoagulants in atrial fibrillation and acute coronary syndromes. ESC working group on thrombosis – task force on anticoagulants in heart disease position paper. J Am Coll Cardiol 2012;59:1413–25
7Sorbera, LA, Bozzo, J, Castaner, J. Dabigatran/dabigatran etexilate. Drugs Fut 2005;30:877–85
8Stangier, J, Eriksson, BI, Dahl, OE, Ahnfelt, L, Nehmiz, G, Stähler, H et al. Pharmacokinetic profile of the oral direct thrombin inhibitor dabigatran etexilate in healthy volunteers and patients undergoing total hip replacement. J Clin Pharmacol 2005;45:555–63
9Eerenberg, ES, Kamphuisen, PW, Sijpkens, MK, Meijers, JC, Buller, HR, Levi, M. Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. Circulation 2011;124:1573–9
10Jiang, J, Hu, Y, Zhang, J, Yang, J, Mueck, W, Kubitza, D et al. Safety, pharmacokinetics and pharmacodynamics of single doses of rivaroxaban – an oral, direct factor Xa inhibitor – in elderly Chinese subjects. Thromb Haemost 2010;103:234–41
11NICE clinical knowledge summaries. In: http://cks.nice.org.uk/anticoagulation-oral#!scenariorecommendation:29 [23 May 2014]
12Massicotte, A. A practice tool for the new oral anticoagulants. Can Pharm J (Ott) 2014;147:2532
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

The Journal of Laryngology & Otology
  • ISSN: 0022-2151
  • EISSN: 1748-5460
  • URL: /core/journals/journal-of-laryngology-and-otology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed